CROSSJECT (EPA:ALCJ) | WebDisclosure

PRESS RELEASE

published on 06/24/2025 at 19:00, 1 year 1 month ago

CROSSJECT annonce le vif succès de son augmentation de capital portée à 5,7 millions d’euros après exercice intégral de la clause d’extension
CROSSJECT annonce le vif succès de son augmentation de capital à 5,7 millions d’euros après exercice intégral de la clause d’extension pour ZEPIZURE®

Financement Augmentation De Capital Pharmaceutique Crossject ZEPIZURE
PRESS RELEASE

published on 06/24/2025 at 19:00, 1 year 1 month ago

CROSSJECT announces a successful capital increase of €5.7 million following full exercise of the extension clause
CROSSJECT successfully completes a capital increase of €5.7 million through preferential subscription rights, benefiting from new investor support and Gemmes Venture, to advance ZEPIZURE® development

Capital Increase Crossject ZEPIZURE® Gemmes Venture Vatel Capital
BRIEF

published on 06/11/2025 at 07:35, 1 year 2 months ago

CROSSJECT advances in the development of ZEPIZURE® Junior for children

Epilepsy Pediatrics Crossject Auto-injector ZEPIZURE Junior
BRIEF

published on 06/11/2025 at 07:35, 1 year 2 months ago

CROSSJECT progresse dans le développement de ZEPIZURE® Junior pour enfants

Pédiatrie Crossject Auto-injecteur Épilepsie ZEPIZURE Junior
PRESS RELEASE

published on 06/11/2025 at 07:30, 1 year 2 months ago

CROSSJECT advances on the development of ZEPIZURE® Junior, its solution for epilepsy crises in children
CROSSJECT advances development of ZEPIZURE® Junior for epilepsy crises in children, completing clinical studies for effective calibration and injection depth validation

Epilepsy Clinical Studies Crossject ZEPIZURE® Junior Pediatric Population
PRESS RELEASE

published on 06/11/2025 at 07:30, 1 year 2 months ago

CROSSJECT avance sur le développement de ZEPIZURE® Junior, sa solution pour les crises d'épilepsie chez l'enfant
CROSSJECT progresse dans le développement de ZEPIZURE® Junior pour les crises d'épilepsie chez l'enfant, avec calibration réussie de ZENEO®. Étude clinique menée pour adapter l'injection aux enfants

Crossject Enfant ZENEO® Épilepsie ZEPIZURE® Junior
BRIEF

published on 06/06/2025 at 17:50, 1 year 2 months ago

Publication des droits de vote et actions de Crossject

Droits De Vote Capital Social Actions AMF Crossject
BRIEF

published on 06/06/2025 at 17:50, 1 year 2 months ago

Publication of Crossject voting rights and shares

Share Capital Voting Rights Actions AMF Crossject
PRESS RELEASE

published on 06/06/2025 at 17:45, 1 year 2 months ago

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
CROSSJECT publie le nombre total de droits de vote et d'actions au 31 mai 2025, incluant les informations sur son capital social et ses activités pharmaceutiques

Droits De Vote Capital Social Pharmaceutique Crossject Urgence
BRIEF

published on 06/04/2025 at 20:26, 1 year 2 months ago

CROSSJECT lance une augmentation de capital de près de 5 millions d'euros

Investissement Augmentation De Capital Pharmaceutique Droit Préférentiel De Souscription ZEPIZURE®

Published on 08/22/2026 at 05:50, 20 hours 40 minutes ago

Battery X Metals Provides Board of Directors Update
Published on 08/22/2026 at 04:55, 21 hours 35 minutes ago

Vanta Announces Closing of First Tranche of Private Placement and Board of Directors Update
Published on 08/22/2026 at 00:30, 1 day 2 hours ago

BioNxt Solutions Inc. Announces Closing of Extension of Convertible Debentures and Issuance of Warrants
Published on 08/21/2026 at 23:00, 1 day 3 hours ago

Tintina Mines Announces Voting Results from its Annual General and Special Meeting of Shareholders
Published on 08/21/2026 at 23:00, 1 day 3 hours ago

Silver Storm Announces $7.5 Million Non-Brokered Private Placement with Eric Sprott

View all ACCESSWIRE

Published on 08/21/2026 at 19:36, 1 day 6 hours ago

EQS-Adhoc: KAP AG ANNOUNCES CHANGE IN SHAREHOLDER STRUCTURE
Published on 08/21/2026 at 19:11, 1 day 7 hours ago

EQS-Adhoc: Marley Spoon Group SE: Discussions with Misfits Market as permanent US fulfillment agent
Published on 08/21/2026 at 18:14, 1 day 8 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/21/2026 at 17:27, 1 day 9 hours ago

EQS-Adhoc: PSI Adjusts Its Forecast for Fiscal Year 2026 in Light of Economic Uncertainties in Europe
Published on 08/21/2026 at 16:30, 1 day 9 hours ago

BL Networks (BLNWX) Details Major Global Infrastructure Expansion and Upgrades

View all EQS

Published on 08/21/2026 at 18:33, 1 day 7 hours ago

260821 BENETEAU Transaction sur actions propres
Published on 08/21/2026 at 08:30, 1 day 18 hours ago

Thales issues a €1bn bond
Published on 08/21/2026 at 08:30, 1 day 18 hours ago

Thales émet un emprunt obligataire de 1 Md€
Published on 08/18/2026 at 18:00, 4 days 8 hours ago

KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 4 days 8 hours ago

Mise à disposition du rapport financier annuel 2025-26

View all LES ECHOS COMFI WIRE

News